# Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/single-dose-eculizumab-as-part-of-a-modified-desensitization-protocol-for-abo/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mario Spaggiari,Egor Petrochenkov,Giulia Bencini,Sujata Gaitonde,Jamie Benken,Grace Guzman,Jamie Berkes,Ivo Tzvetanov,Enrico Benedetti |
| Citations | 3 |
| DOI | 10.1097/lvt.0000000000000120 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4323294748 |
| PMID | 36876445 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Egor Petrochenkov](https://scholariq.org/researchers/egor-petrochenkov/)

## Paper primary topic

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

## Paper topics

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.